http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08291172-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c275038cf36535d44a526cb28203c03d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
filingDate 1996-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd3fc6c458224b1fd851ce9c0cea66e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2257760368ca221b2cf233f3a4e1b6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4d7e987ab3e209edd8cbe122497383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0cc66636f2456991a175b2a1bd24ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c770f626e2711795fecd8766713016c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a4d644e2cc5541c5a359d428337ff9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8265421f99a8ff0ace3546d44aa58061
publicationDate 1996-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08291172-A
titleOfInvention Novel pyridine compounds, process for their production and pharmaceutical compositions containing them
abstract (57) Abstract: A novel pyridine compound having a high affinity for a melatoninergic receptor and useful for the treatment of sleep disorders, a method for producing the same, and a pharmaceutical composition containing the same. provide. SOLUTION: Formula (I): [In the formula, R 1 , R 2 , R 3 and R 4 are hydrogen, halogen, alkyl, alkoxy and the like; R 5 is a group represented by the formula —AB— Y {in the formula, A is C 1 -C 6 alkylene, B is a group -N (R 6) C (= Z ) -, - N (R 6) C (= Z) -NH - or -C (= Z) N (R 6) - Table by (wherein, R 6 is hydrogen, alkyl etc., Z is oxygen or sulfur and which) is, Y represents hydrogen, and the like or alkyl} Done; X Is oxygen, sulfur or a group -N (R 7) (wherein, R 7 is Hydrogen, alkyl, etc.], a method for producing the same, and a pharmaceutical composition containing the same.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017513915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5227806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007238612-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006520771-A
priorityDate 1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896

Total number of triples: 34.